92,500 Shares in ICU Medical, Inc. (NASDAQ:ICUI) Bought by Pacific Capital Partners Ltd

Pacific Capital Partners Ltd purchased a new stake in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 92,500 shares of the medical instruments supplier's stock, valued at approximately $12,845,000. ICU Medical comprises about 8.1% of Pacific Capital Partners Ltd's investment portfolio, making the stock its 2nd biggest position. Pacific Capital Partners Ltd owned about 0.38% of ICU Medical at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Quarry LP lifted its holdings in ICU Medical by 764.3% in the 4th quarter. Quarry LP now owns 242 shares of the medical instruments supplier's stock valued at $38,000 after purchasing an additional 214 shares in the last quarter. Russell Investments Group Ltd. grew its position in ICU Medical by 88.8% in the fourth quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock valued at $99,000 after acquiring an additional 300 shares in the last quarter. Sterling Capital Management LLC boosted its stake in shares of ICU Medical by 813.5% during the 4th quarter. Sterling Capital Management LLC now owns 676 shares of the medical instruments supplier's stock valued at $105,000 after buying an additional 602 shares during the last quarter. GAMMA Investing LLC lifted its stake in ICU Medical by 27.2% during the first quarter. GAMMA Investing LLC now owns 716 shares of the medical instruments supplier's stock worth $99,000 after purchasing an additional 153 shares during the last quarter. Finally, Blue Trust Inc. lifted its stake in ICU Medical by 23.0% during the first quarter. Blue Trust Inc. now owns 801 shares of the medical instruments supplier's stock worth $111,000 after purchasing an additional 150 shares during the last quarter. 96.10% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

ICUI has been the topic of a number of research analyst reports. Raymond James Financial lowered their price target on ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating on the stock in a report on Friday, May 9th. Wall Street Zen upgraded ICU Medical from a "hold" rating to a "buy" rating in a report on Sunday, May 18th. Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a research note on Tuesday, April 8th. Finally, KeyCorp dropped their price target on ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Buy" and an average price target of $192.67.

ICU Medical Trading Down 0.8%

NASDAQ ICUI traded down $1.01 on Friday, reaching $127.40. The company had a trading volume of 242,224 shares, compared to its average volume of 250,633. ICU Medical, Inc. has a 52 week low of $117.92 and a 52 week high of $196.26. The stock's 50 day moving average is $130.65 and its 200-day moving average is $141.97. The stock has a market cap of $3.14 billion, a price-to-earnings ratio of -33.26 and a beta of 0.87. The company has a quick ratio of 1.52, a current ratio of 2.59 and a debt-to-equity ratio of 0.75.

ICU Medical (NASDAQ:ICUI - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share for the quarter, topping the consensus estimate of $1.23 by $0.49. ICU Medical had a positive return on equity of 6.75% and a negative net margin of 3.87%. The company had revenue of $599.49 million during the quarter, compared to analysts' expectations of $574.15 million. During the same period in the prior year, the firm earned $0.96 earnings per share. ICU Medical's revenue for the quarter was up 6.7% compared to the same quarter last year. Equities analysts predict that ICU Medical, Inc. will post 4.11 earnings per share for the current year.

Insider Transactions at ICU Medical

In other news, COO Christian B. Voigtlander sold 5,556 shares of the business's stock in a transaction dated Wednesday, May 14th. The stock was sold at an average price of $138.65, for a total value of $770,339.40. Following the transaction, the chief operating officer directly owned 2,389 shares of the company's stock, valued at $331,234.85. The trade was a 69.93% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Ben Sousa sold 2,000 shares of the company's stock in a transaction that occurred on Thursday, May 15th. The stock was sold at an average price of $137.36, for a total value of $274,720.00. Following the transaction, the insider directly owned 479 shares in the company, valued at approximately $65,795.44. This trade represents a 80.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 36,097 shares of company stock worth $4,860,156 in the last ninety days. 1.50% of the stock is currently owned by company insiders.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.